Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

Nasuh C. Buyukkaramikli*, Saskia de Groot, Debra Fayter, Robert Wolff, Nigel Armstrong, Lisa Stirk, Gill Worthy, Fernando Albuquerque de Almeida, Jos Kleijnen, Maiwenn J. Al

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)145-159
Number of pages15
JournalPharmacoeconomics
Volume36
Issue number2
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • LOW-DOSE DEXAMETHASONE
  • COMBINATION
  • SURVIVAL
  • BENDAMUSTINE
  • THALIDOMIDE
  • THERAPY
  • DISEASE
  • TRIAL

Cite this